CDK2 and cancer: These literature data are consistent with the observed growth arrest in the Ca9-22 cancer cell populations in the G2 or M phase by W-R EtOAc (125 μM) and W-R BuOH (250 μM) and highlight the involvement of CDK2 inhibition of as a molecular anticancer mechanism.